326 related articles for article (PubMed ID: 31915059)
1. Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients.
Meyer A; Troyanov Y; Drouin J; Oligny-Longpré G; Landon-Cardinal O; Hoa S; Hervier B; Bourré-Tessier J; Mansour AM; Hussein S; Morin V; Rich E; Goulet JR; Chartrand S; Hudson M; Nehme J; Makhzoum JP; Zarka F; Villeneuve E; Raynauld JP; Landry M; O'Ferrall EK; Ferreira J; Ellezam B; Karamchandani J; Larue S; Massie R; Isabelle C; Deschênes I; Leclair V; Couture H; Targoff IN; Fritzler MJ; Senécal JL
Arthritis Res Ther; 2020 Jan; 22(1):5. PubMed ID: 31915059
[TBL] [Abstract][Full Text] [Related]
2. Anti-HMGCR Myopathy.
Mohassel P; Mammen AL
J Neuromuscul Dis; 2018; 5(1):11-20. PubMed ID: 29480216
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
Mammen AL; Chung T; Christopher-Stine L; Rosen P; Rosen A; Doering KR; Casciola-Rosen LA
Arthritis Rheum; 2011 Mar; 63(3):713-21. PubMed ID: 21360500
[TBL] [Abstract][Full Text] [Related]
4. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype.
Troyanov Y; Landon-Cardinal O; Fritzler MJ; Ferreira J; Targoff IN; Rich E; Goulet M; Goulet JR; Bourré-Tessier J; Robitaille Y; Drouin J; Albert A; Senécal JL
Medicine (Baltimore); 2017 Jan; 96(3):e5694. PubMed ID: 28099331
[TBL] [Abstract][Full Text] [Related]
6. Statin-induced anti-HMGCR antibody-related immune-mediated necrotising myositis achieving complete remission with rituximab.
Zhang W; Prince HM; Reardon K
BMJ Case Rep; 2019 Dec; 12(11):. PubMed ID: 31791994
[TBL] [Abstract][Full Text] [Related]
7. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
[TBL] [Abstract][Full Text] [Related]
8. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL
Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019
[TBL] [Abstract][Full Text] [Related]
9. Immune-mediated necrotizing myopathy associated with statins: history and recent developments.
Tiniakou E; Christopher-Stine L
Curr Opin Rheumatol; 2017 Nov; 29(6):604-611. PubMed ID: 28857949
[TBL] [Abstract][Full Text] [Related]
10. Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin-Associated Immune-Mediated Necrotizing Myopathy: A Case Series.
Tiniakou E; Rivera E; Mammen AL; Christopher-Stine L
Arthritis Rheumatol; 2019 Oct; 71(10):1723-1726. PubMed ID: 31058470
[TBL] [Abstract][Full Text] [Related]
11. Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins.
Khan F; Brady S; Kuttikat A
Rheumatol Int; 2023 Feb; 43(2):383-390. PubMed ID: 36260115
[TBL] [Abstract][Full Text] [Related]
12. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
[TBL] [Abstract][Full Text] [Related]
13. Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort.
Waters MJ; Limaye V
Clin Rheumatol; 2018 Feb; 37(2):543-547. PubMed ID: 28905130
[TBL] [Abstract][Full Text] [Related]
14. Is statin-induced myositis part of the polymyositis disease spectrum?
Albayda J; Mammen AL
Curr Rheumatol Rep; 2014 Aug; 16(8):433. PubMed ID: 24996782
[TBL] [Abstract][Full Text] [Related]
15. Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum".
Hamann PD; Cooper RG; McHugh NJ; Chinoy H
Autoimmun Rev; 2013 Oct; 12(12):1177-81. PubMed ID: 23851103
[TBL] [Abstract][Full Text] [Related]
16. More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
Tiniakou E; Pinal-Fernandez I; Lloyd TE; Albayda J; Paik J; Werner JL; Parks CA; Casciola-Rosen L; Christopher-Stine L; Mammen AL
Rheumatology (Oxford); 2017 May; 56(5):787-794. PubMed ID: 28096458
[TBL] [Abstract][Full Text] [Related]
17. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
Aggarwal R; Moghadam-Kia S; Lacomis D; Malik A; Qi Z; Koontz D; Burlingame RW; Oddis CV
Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
[No Abstract] [Full Text] [Related]
18. Maintenance treatment with subcutaneous immunoglobulins in the long-term management of anti-HMCGR myopathy.
Zuppa A; De Michelis C; Meo G; Prada V; Gemelli C; Infantino M; Manfredi M; Pesce G; Tagliafico AS; Benedetti L; Fiorillo C; Schenone A; Quartuccio L; Grandis M
Neuromuscul Disord; 2021 Feb; 31(2):134-138. PubMed ID: 33461845
[TBL] [Abstract][Full Text] [Related]
19. Atypical presentation of anti-HMGCR myopathy.
Karna R; Singh R; Marshall C; Johnston A
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34544705
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune necrotising myopathy and HMGCR antibodies.
Karunaratne K; Amiras D; Pickering MC; Hofer M; Viegas S
Pract Neurol; 2018 Apr; 18(2):151-155. PubMed ID: 29439058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
